Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CFO David Mountcastle sold 3,933 shares of the stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total value of $69,889.41. Following the completion of the transaction, the chief financial officer now owns 262,279 shares of the company's stock, valued at approximately $4,660,697.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Privia Health Group Stock Up 0.7 %
PRVA opened at $18.38 on Friday. The firm has a market cap of $2.18 billion, a P/E ratio of 96.74, a PEG ratio of 2.49 and a beta of 0.81. The business's fifty day simple moving average is $20.59 and its 200 day simple moving average is $21.71. Privia Health Group, Inc. has a 52 week low of $17.54 and a 52 week high of $30.15.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The firm had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. Privia Health Group's revenue for the quarter was up 21.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.14 earnings per share. As a group, equities analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Elon’s New A.I. Device is About to Shock the World
From InvestorPlace | Ad
Using this device you see above…
Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in…
“The next step in human evolution.”
Click here to see the details because there’s a lot of money at stake.
PRVA has been the topic of a number of recent analyst reports. TD Cowen lowered their price target on shares of Privia Health Group from $30.00 to $26.00 and set an "outperform" rating on the stock in a research note on Friday, March 1st. Evercore ISI dropped their target price on shares of Privia Health Group from $26.00 to $25.00 and set an "outperform" rating for the company in a report on Wednesday, February 28th. UBS Group reduced their price target on shares of Privia Health Group from $31.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, March 1st. Truist Financial lowered their price target on Privia Health Group from $32.00 to $28.00 and set a "buy" rating on the stock in a report on Thursday, February 29th. Finally, Jefferies Financial Group assumed coverage on Privia Health Group in a research report on Monday, February 26th. They set a "buy" rating and a $25.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Privia Health Group presently has an average rating of "Moderate Buy" and an average price target of $28.58.
Read Our Latest Analysis on PRVA
Institutional Trading of Privia Health Group
Hedge funds and other institutional investors have recently bought and sold shares of the company. C M Bidwell & Associates Ltd. acquired a new stake in shares of Privia Health Group during the second quarter worth $38,000. Tower Research Capital LLC TRC boosted its stake in Privia Health Group by 171.1% in the 1st quarter. Tower Research Capital LLC TRC now owns 1,578 shares of the company's stock worth $44,000 after buying an additional 996 shares during the last quarter. Point72 Hong Kong Ltd acquired a new stake in Privia Health Group in the 1st quarter worth about $47,000. Neo Ivy Capital Management purchased a new stake in Privia Health Group in the 2nd quarter valued at about $53,000. Finally, Benjamin Edwards Inc. acquired a new position in shares of Privia Health Group during the 2nd quarter valued at about $58,000. 94.48% of the stock is owned by hedge funds and other institutional investors.
About Privia Health Group
(
Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
